News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
665,074 Results
Type
Article (55033)
Company Profile (699)
Press Release (609342)
Section
Business (185205)
Career Advice (2558)
Deals (33507)
Drug Delivery (92)
Drug Development (74879)
Employer Resources (130)
FDA (15880)
Job Trends (15596)
News (317803)
Policy (31002)
Tag
Academia (2775)
Alliances (44891)
Alzheimer's disease (1302)
Approvals (15852)
Artificial intelligence (154)
Bankruptcy (280)
Best Places to Work (12261)
Biotechnology (486)
Breast cancer (196)
Cancer (1460)
Cardiovascular disease (115)
Career advice (2113)
Cell therapy (310)
Clinical research (59809)
Collaboration (538)
Compensation (300)
COVID-19 (2372)
C-suite (128)
Data (1457)
Diabetes (165)
Diagnostics (6476)
Earnings (71817)
Employer resources (114)
Events (109159)
Executive appointments (465)
FDA (16645)
Funding (497)
Gene therapy (209)
GLP-1 (573)
Government (4212)
Healthcare (20222)
Infectious disease (2461)
Inflammatory bowel disease (120)
Interviews (435)
IPO (16579)
Job creations (3835)
Job search strategy (1843)
Layoffs (400)
Legal (6883)
Lung cancer (211)
Manufacturing (221)
Medical device (14076)
Medtech (14080)
Mergers & acquisitions (17229)
Metabolic disorders (441)
Neuroscience (1648)
NextGen: Class of 2025 (7319)
Non-profit (4948)
Northern California (1828)
Obesity (237)
Opinion (226)
Patents (122)
People (54427)
Pharmaceutical (137)
Phase I (18511)
Phase II (26009)
Phase III (20206)
Pipeline (531)
Postmarket research (2482)
Preclinical (8037)
Radiopharmaceuticals (256)
Rare diseases (267)
Real estate (6310)
Regulatory (21437)
Research institute (2514)
Resumes & cover letters (415)
Southern California (1589)
Startups (3481)
United States (16879)
Vaccines (512)
Weight loss (165)
Date
Last 7 days (872)
Last 30 days (1882)
Last 365 days (36061)
2025 (973)
2024 (36666)
2023 (41390)
2022 (51564)
2021 (56186)
2020 (55977)
2019 (49800)
2018 (37213)
2017 (31876)
2016 (30598)
2015 (35988)
2014 (28825)
2013 (28474)
2012 (24993)
2011 (25254)
2010 (23711)
Location
Africa (838)
Arizona (143)
Asia (38925)
Australia (6988)
California (4214)
Canada (1510)
China (345)
Colorado (187)
Connecticut (213)
Europe (88731)
Florida (587)
Georgia (149)
Illinois (432)
Indiana (247)
Maryland (712)
Massachusetts (3388)
Michigan (200)
Minnesota (332)
New Jersey (1200)
New York (1182)
North Carolina (899)
Northern California (1828)
Ohio (160)
Pennsylvania (995)
South America (1159)
Southern California (1589)
Texas (612)
Utah (122)
Washington State (461)
665,074 Results for "new wave surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Huntington’s disease
Takeda Walks Away From Wave Huntington’s Partnership After Sinking $260M in Collaboration
Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on Wave’s WVE-003 clinical-stage Huntington’s disease program—a potential $5 billion commercial opportunity, according to the biotech.
October 16, 2024
·
3 min read
·
Tristan Manalac
Press Releases
New Wave Endo Has Been Recognized on the 2024 Inc. 5000 List of Fastest-Growing Companies and Was the #1 Fastest-Growing Surgical Device Company
August 28, 2024
·
2 min read
Alzheimer’s
Leqembi, Kisunla and Beyond: The Next Wave of Alzheimer’s at CTAD 2024
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s Disease conference focused on the role these drugs might play, as well as combination therapies and innovative new treatment options.
November 11, 2024
·
6 min read
·
Kate Goodwin
Press Releases
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
October 31, 2024
·
9 min read
Press Releases
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
December 16, 2024
·
5 min read
Press Releases
Wave Life Sciences to Present at Upcoming Investor Conferences
November 26, 2024
·
1 min read
Alzheimer’s disease
New Wave of Alzheimer’s Therapies Actively Engage the Immune System
Active immune therapies hold promise for preventing or slowing disease onset, but some experts warn of potential safety risks.
August 5, 2024
·
5 min read
·
Gail Dutton
Series B
Adcendo Rides ADC Wave With $135M Series B
Adcendo joins a growing group of biotechs working to usher the next generation of antibody-drug conjugates to the market.
November 25, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 16, 2024
·
1 min read
Press Releases
Wave Life Sciences to Present at Jefferies London Healthcare Conference
November 15, 2024
·
1 min read
1 of 66,508
Next
